1 / 3

Americas Blood Glucose Monitoring Market

Americas Blood Glucose Monitoring Market is expected to grow USD 1.64 Billion at a CAGR 6.40% during the forecast period 2023 to 2030.

Khusi1
Download Presentation

Americas Blood Glucose Monitoring Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Introduction Americas Blood Glucose Monitoring Market is expected to grow USD 1.64 Billion at a CAGR 6.40% during the forecast period 2023 to 2030. Diabetes is a global health epidemic, affecting millions of people worldwide. In the Americas, the prevalence of diabetes has been steadily increasing, driving the demand for advanced tools and technologies to manage the condition effectively. One of the cornerstones of diabetes management is blood glucose monitoring. Over the years, the Americas Blood Glucose Monitoring Market has seen remarkable advancements in technology, ease of use, and accessibility. This article explores the current landscape of blood glucose monitoring in the Americas, highlighting key trends, challenges, and innovations that are shaping the future of diabetes care in the region. Key Companies in the Americas Blood Glucose Monitoring Market Includes • Sanofi (France) • GlySure Ltd (U.K) • Sphere Medical Holding plc. (UK) • Abbott Laboratories (US) • Arkay, Inc. (US) • Bayer Healthcare AG (Germany) • Hoffmann-La Roche Ltd (Switzerland) • Dexcom, Inc. (US)and • LifeScan, Inc. (US) • Novo Nordisk (Denmark) Americas Blood Glucose Monitoring Product Insights The blood glucose monitoring market segmentation, based on product, includes self-monitoring blood glucose devices, and continuous blood glucose monitoring devices. The self-monitoring blood glucose devices segment held the majority share in 2021 in respect to the market revenue of blood glucose monitoring. This is primarily owing to the low cost and ease of use. It is also considered an important element of diabetes management daily. Self-monitoring of blood sugar is an approach wherein people measure their blood sugar levels with the help of a glucose meter. It is sub- segmented into blood glucose meter, testing strips, and lancets. The Americas Blood Glucose Monitoring Market has evolved significantly over the years. Here is an overview of the current landscape: 1.Traditional Fingerstick Testing: Fingerstick testing with glucose meters has been the standard method of blood glucose monitoring for decades. While these devices are accurate, they require regular finger pricking, which can be uncomfortable and inconvenient for some patients. 2.Continuous Glucose Monitoring (CGM) Systems: CGM systems have gained popularity for their ability to provide real-time glucose data without the need for frequent fingerstick tests. These systems consist of a sensor inserted under the skin that continuously measures

  2. glucose levels and transmits data to a receiver or smartphone app. CGM systems offer a more comprehensive view of glucose fluctuations, helping individuals and healthcare providers make more informed decisions. 3.Flash Glucose Monitoring: Flash glucose monitoring is a newer technology that combines some features of traditional glucose meters and CGM systems. Users wear a small sensor on their skin, which they can scan with a reader or smartphone to obtain glucose readings. This approach offers convenience and reduces the need for regular fingerstick tests. 4.Mobile Health Apps: The proliferation of smartphones has led to the development of mobile health apps that allow individuals to track and manage their blood glucose levels digitally. These apps often integrate with various monitoring devices and provide valuable insights into glucose trends over time. Americas Blood Glucose Monitoring Application Insights The market segment of blood glucose monitoring, based on application, includes Type 1 diabetes, and type 2 diabetes. The type 2 diabetes segment dominated the market in 2021 in respect to the blood glucose monitoring market revenue. This is due to the increasing incidence of type 2 diabetes and increasing innovative product launches with less invasive technologies. Hence, rising incidence of type 2 diabetes will positively impacts the blood glucose monitoring market growth. Americas Blood Glucose Monitoring End User Insights The market segment of blood glucose monitoring, based on end user, includes hospitals & clinics, diagnostic centers, and others. The hospitals and clinics held the largest market share in 2021 in respect to the blood glucose monitoring market revenue. This is owing to the improving infrastructure and increasing healthcare expenditure in hospitals and clinics. Moreover, the reliable data that blood glucose monitoring devices provide practitioners in a fraction of seconds and the improvement in patients' quality of life have increased their adoption in the outpatient as well as inpatient hospital and clinic settings. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 628 258 0071

  3. Email: sales@marketresearchfuture.com

More Related